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2.3. Other
2.3.1. Non-ischemic cardiomyopathy
2.3.2. Arrhythmogenic right ventricular cardiomyopathy (ARVC)
2.3.3. Congenital heart disease
2.3.4. Valvular heart disease
2.3.5. Pericardial disease
2.3.6. Masses
1. General Techniques
1.1. Stress equipment and safety
Equipment
1. Monitoring equipment (blood pressure, electrocardio-
gram for monitoring of cardiac rhythm, intercom to com-
municate with patient)
2. Preparation and regular practice for rapid removal of
the patient from the magnet
3. Emergency resuscitation policy in place
4. Defibrillator
5. Drugs for emergency treatment
a. Immediately at hand: β-blocker (eg esmolol or meto-
prolol), nitroglycerin, aminophylline
b. In the emergency cart: full set of emergency drugs
(including drugs such as: epinephrine, beta blockers, atro-
pine, bronchodilators, antiarrhythmic drugs)
6. For dobutamine – on-line assessment of wall motion
during image reconstruction performed immediately after
image acquisition
Stress agents
Dobutamine typical maximum dose of 40 ug/kg/min
Atropine 0.25 mg fractions typical (maximal dose 2 mg)
Adenosine 140 μg/kg body weight/min
Contraindications
Dobutamine
￿ Severe systemic arterial hypertension (≥ 220/120
mmHg)
￿ Unstable angina pectoris
￿ Significant aortic valve stenosis (Peak aortic valve gradi-
ent > 50 mmHg or aortic valve area < 1 cm2)
￿ Complex cardiac arrhythmias including uncontrolled
atrial fibrillation
￿ Hypertrophic obstructive cardiomyopathy
￿ Myocarditis, endocarditis, pericarditis
￿ Uncontrolled congestive heart failure
Adenosine
￿ Known hypersensitivity to adenosine
￿ Known or suspected bronchoconstrictive or bronchos-
pastic disease
￿ 2nd or 3rd degree atrioventricular (AV) block
￿ Sinus bradycardia (heart rate < 45 bpm)
￿ Systemic arterial hypotension (< 90 mmHg)
Atropine
￿ Narrow-angle glaucoma
￿ Myasthenia gravis
￿ Obstructive uropathy
￿ Obstructive gastrointestinal disorders
Patient preparation
1. Obtain informed consent for the stress test
2. To fully exert its effects patients should refrain from the
following medications for at least 24 hours prior to the
examination due to potential of counteraction against
stress agent:
Dobutamine: β-blockers and nitrates
Adenosine: caffeine (coffee, tee, caffeinated beverages or
foods e.g. chocolate, caffeinated medications), theophyl-
line, dipyridamoleJournal of Cardiovascular Magnetic Resonance 2008, 10:35 http://www.jcmr-online.com/content/10/1/35
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3. Fasting is not usually considered mandatory, but is
sometimes advised because recognized adverse effects of
stress drugs include nausea and vomiting, which is prob-
lematic when lying supine in the restricted space of the
magnet
Potential adverse effects
Dobutamine at high doses may cause chest pain, palpita-
tions. More severe complications are uncommon, includ-
ing:
￿ infarction
￿ ventricular fibrillation
￿ sustained ventricular tachycardia
Adenosine may cause flushing, chest pain, palpitations,
breathlessness. More severe side effects include
￿ transient heart block
￿ transient hypotension
￿ transient sinus tachycardia
￿ bronchospasm
1.2. Left ventricular structure and function module
1. Scout imaging – transtransaxial, coronal, sagittal
2. Transaxial (8–10 mm) set of steady state free precession
(SSFP) or fast spin echo images through the chest.
3. Scout to line up short axis images – cine acquisitions are
preferable to single shot as long axis motion and inflow
should be visualized
a. Vertical long axis prescribed orthogonal to transaxial
scouts aligned through the apex and center of the mitral
valve
b. Horizontal long axis aligned orthogonal to the vertical
long axis, passing through the apex and center of the
mitral valve
4. Steady state free precession short axis cine images, from
the mitral valve plane through the apex. The basal most
short axis slice should be located immediately on the
myocardial side of the atrioventricular junction at end-
diastole prescribed from the previously acquired long axis
cines.
a. Slice thickness 6–8 mm, with 2–4 mm interslice gaps to
equal 10 mm.
b. Temporal resolution ≤ 45 ms between phases
c. Parallel imaging used as available
5. Steady state free precession long axis cine images
a. The 4 chamber long axis is prescribed from the vertical
long axis through the apex and center of the mitral and tri-
cuspid valves. This can be cross-checked on basal short
axis cines, using the costophrenic angle (margin) of the
RV free wall.
b. Vertical long axis, prescribed from the scout already
acquired
c. LV outflow tract (LVOT) long axis, passing through the
apex, the center of the mitral valve and aligned with the
center of LVOT to aortic valve, as seen on a basal short axis
cine.
d. Optional – a set of more than 3 rotational long axis
views can be obtained.
6. Analysis
a. All short axis images are evaluated with computer-aided
analysis packages for planimetry of endocardial and epi-
cardial borders at end-diastole and end-systole. More
advanced software automatically adjusts for systolic atrio-
ventricular ring descent.
b. The inclusion or exclusion of papillary muscles in the
LV mass should be the same as that used in normal refer-
ence ranges used for comparison.
c. Care must be used at the 1 or 2 most basal slices. Due to
systolic movement of the base towards the apex in nor-
mally contractile ventricles, the end-systolic phase will
include only left atrium. This may not be the case in a
severely dysfunctional LV. Either way, this slice at end-
diastole will include LV mass and volume.
1.3. Right ventricular structure and function
1. Right ventricular (RV) short axis views can be obtained
in a similar fashion to the LV structure and function mod-
ule. If the short axis is used for quantification, it is impor-
tant to place the basal short axis slice immediately on the
myocardial side of the right ventricle and to take extra care
to exclude appropriate amounts of atrial volume from at
least one basal slice at end systole.
2. Transaxial stack of cines covering the RV enable best
identification of the tricuspid valve plane.Journal of Cardiovascular Magnetic Resonance 2008, 10:35 http://www.jcmr-online.com/content/10/1/35
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3. Long axis images should include an RV vertical long
axis view aligned with tricuspid inflow and a RV outflow
tract view (sagittal plane through the pulmonary valve).
4. Analysis
a. A similar computer-aided analytic approach is required
as for the left ventricle.
b. Care must be taken with RV trabeculations and with the
RV outflow tract after repair of tetralogy of Fallot with a
consistent approach used for longitudinal comparison.
1.4. Gadolinium dosing module
Notes:
1. Volumes and injection rates depend on scan duration:
the given values are recommendations for typical scan
times.
2. Injection rates are different for 1 molar contrast agents.
As a general rule, divide the given injection rates by a fac-
tor of 2.
3. Contrast agents with higher relaxivity (e.g., gadobenate
dimeglumine) require smaller doses.
4. Throughout the protocols, the term "gadolinium" refers
to gadolinium chelates
5. Injection rate for peripheral angiography with elliptic-
centric readouts may be different than those specified
below.
See Table 1.
1.5. First pass perfusion module
1. Scout imaging as per LV structure and function module
2. Saturation-recovery imaging with gradient echo-echo
planar (GRE-EPI) hybrid, GRE, or SSFP readout
3. Short-axis view imaging (at least 3 slices per heart beat)
a. For ischemia evaluation, must obtain data every heart
beat
b. Slice thickness 8 mm
c. Parallel imaging, 2-fold acceleration, if available
d. In-plane resolution, ~< 3 mm
e. Readout temporal resolution ~100 – 125 ms or shorter
as available
f. Contrast is given (0.05 – 0.1 mmol/kg, 3–7 ml/s) fol-
lowed by at least 30 ml saline flush (3–7 ml/sec)
g. Breathhold starts during early phases of contrast infu-
sion before contrast reaches the LV cavity.
h. Image for 40–50 heart beats by which time contrast has
passed through the LV myocardium
1.6. Late gadolinium enhancement module
1. Need at least 10 minute wait after gadolinium injection
(0.1–0.2 mmol/kg). Note – The delay may be shorter than
10 minutes if lower doses are used as blood pool signal
falls below that of late enhanced myocardium.
2. 2D segmented inversion recovery GRE imaging during
diastolic stand-still
3. Same views as for cine imaging (short- and long-axis
views)
4. Slice thickness, same as for cine imaging
Table 1: Contrast and chasing bolus doses and injection rates
Indication contrast dose 
(mmol/kg body weight unless 
otherwise stated)
injection rate chasing 
bolus
 (NaCl)
injection rate
Perfusion 0.05–0.1 3–7 ml/s 30 ml 3–7 ml/s
Late gadolinium 
enhancement
0.1–0.2 20 ml
Angiography 
(carotids, renals, thoracic or 
abdominal Aorta)
0.1–0.2 2–3 ml/s 20 ml 2–3 ml/s
Time-resolved 
angiography
10 ml 3–5 ml/s 30 ml 4 ml/s
Peripheral angiography 0.2 mmol/kg first 10 ml @ 1.5 ml/s, 
rest @ 0.4–0.8
ml/s
20 ml 0.4–0.8 ml/sJournal of Cardiovascular Magnetic Resonance 2008, 10:35 http://www.jcmr-online.com/content/10/1/35
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5. In-plane resolution, ~1.4–1.8 mm
6. Acquisition duration per R-R interval below 200 ms but
should be less in the setting of tachycardia.
7. Inversion time set to null normal myocardium. Alterna-
tive is to use fixed TI with a phase-sensitive sequence.
8. Read-out is usually every other heart beat but should be
modified to every heart beat in the setting of bradycardia,
and every third heart beat in the setting of tachycardia or
arrhythmia.
9. Optional
a. Single-shot imaging (SSFP readout) performed as
backup for patients with irregular heart beat, difficulty
breath holding.
b. 3D sequences with parallel imaging in appropriate
patients if signal-to-noise is sufficient.
10. Analysis
a. Interpret visually using AHA 17-segment model.
b. Estimate area (mean transmural extent) of enhance-
ment within each segment (0%, 1–25%, 26–50%, 51–
75%, 76–100%).
2. Disease specific protocols -
2.1. Ischemic heart disease
2.1.1. Acute myocardial infarction
1. LV structure and function module
2. Optional – T2 weighted imaging (see nonischemic car-
diomyopathies protocol for sequence details) (at least
areas with wall motion abnormalities)
3. First pass perfusion module (only at rest)
4. To look for microvascular obstruction, scan for consider
repeat first pass perfusion sequence or early gadolinium
enhancement, i.e within the first 1–3 minutes after con-
trast infusion
5. Late gadolinium enhancement module
2.1.2. Chronic ischemic heart disease and viability
1. LV structure and function module
2. Optional – low dose dobutamine with 5–10 minute
infusion of 10 μg/kg/min of dobutamine to assess con-
tractile reserve as improvement in wall thickening
3. Optional – adenosine stress-rest perfusion or high dose
dobutamine functional imaging (see stress protocols for
more details) to determine the presence of inducible per-
fusion deficits or wall motion abnormalities
4. Late Gadolinium Enhancement module
5. Analysis
a. Helpful to view cines and LGE images of equivalent
planes side-by-side
b. Interpret using both cine and LGE data. For example,
"region is dysfunctional but viable".
2.1.3. Dobutamine stress CMR
1. LV structure and function module
2. Dobutamine stimulation
a. Increase the dobutamine in increments of 10 μg/kg
body weight/minute every 3 minutes starting at 10 μg/kg
body weight/minute until target heart rate [85% × (220-
age)] reached.
b. Add atropine in small incremental doses, if heart rate
response is poor.
c. Repeat 3 short axis and 3 long axis cine views during
each increment
d. Continuous ECG monitoring and BP measured during
each stage.
e. View cine loops online as they are being acquired.
f. Adapt the SSFP cine sequence to optimize temporal res-
olution as needed as the heart rate increases.
g. Stop test for new wall motion abnormality, serious side
effect, or achievement of peak heart rate.
3. Analysis
a. View cines in multiscreen format, reviewing rest, inter-
mediate stress levels and peak stress at the same time in a
synchronized fashion.
b. Describe wall motion as normokinetic, mild hypoki-
netic, severe hypokinetic, akinetic and dyskinetic for all 17
segments.
c. Report inducible wall motion abnormalities and viabil-
ity.Journal of Cardiovascular Magnetic Resonance 2008, 10:35 http://www.jcmr-online.com/content/10/1/35
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2.1.4. Adenosine stress perfusion CMR
1. LV structure and function module (alternatively this
can be performed between stress and rest perfusion,
although performance immediately after gadolinium
infusion may reduce the contrast of the blood-endocar-
dium interface)
2. Two intravenous lines should be available, one for
gadolinium and one for adenosine, one in each arm. Pref-
erential site of contrast infusion is antecubital. Blood pres-
sure cuff should be used with care taken not to interfere
with gadolinium or adenosine infusion.
3. Adenosine stress perfusion imaging (at least 3 minute
infusion of 140 ug/kg body weight/min). Option – initial
adenosine infusion may be performed with the patient
outside the bore of the magnet.
a. First pass perfusion module
b. During last minute of adenosine, gadolinium is
injected
c. After imaging for 40–50 heart beats by which time
gadolinium has passed through the LV myocardium, ade-
nosine is stopped.
d. Continous ECG monitoring and BP measured at base-
line, during infusion, and for at least 2 minutes post-infu-
sion of adenosine.
4. Rest Perfusion
a. Need at least 10 minute wait for gadolinium to wash
out from stress perfusion imaging. During this period
stress images can be reviewed, cine imaging can be com-
pleted (e.g long-axis views), valvular evaluation can be
performed, etc.
b. Perfusion imaging repeated without adenosine using
same dose of gadolinium
c. If stress images are normal and free of artifacts, rest per-
fusion can be skipped. Additional gadolinium may be
given as needed for late gadolinium enhancement (for a
total of 0.1 – 0.2 mmol/kg)
5. Late Gadolinium Enhancement module
a. Need to wait at least 5 minutes after rest perfusion
6. Analysis
a. Interpret visually using 17 segment AHA segment
model (16-segment model can be used, leaving out apex)
b. Optional – Quantitative analysis of the inflow curves
could be considered in cases without obvious visual per-
fusion defect.
c. Helpful to view cines, stress and rest perfusion, and LGE
images all side-by-side in equivalent slices
2.2. Angiography
2.2.1. Peripheral MRA
1. Peripheral vascular coil, or combination of coils, as
available. Venous compression cuffs (placed on the
thighs, and inflated to sub-diastolic pressure) are helpful,
if available.
2. Transaxial, low-resolution, vessel scouting with time-
of-flight MRA or SSFP.
3. Gadolinium timing
a. Option 1 -Transaxial test bolus at level of distal abdom-
inal aorta. 2 ml injection of gadolinium, followed by 20
ml saline. Determine time to peak enhancement follow-
ing injection using a single-shot bolus tracking sequence.
b. Option 2 – Bolus trigger technique to time start of scan
4. Stepping-table, gadolinium-enhanced MRA performed
in the coronal projection from the mid abdominal aorta
to the feet.
a. Two volumetric acquisitions – one pre-contrast (for
subtraction) and one during contrast administration.
b. Gadolinium injected in 2 phases to minimize venous
contamination followed by saline bolus.
c. Slice thickness 1–1.5 mm; acquired spatial resolution
in-plane 0.8–1.5 mm.
d. Slices – typically 60–80, as needed to accommodate
vessels of interest.
e. Volumes obtained of abdomen/pelvis and thighs may
be coarser spatial resolution (larger vessels), while those
of the legs preferably are sub-millimeter spatial resolu-
tion. The former acquisitions typically require 15–20 sec-
onds, while the leg acquisition may take 60–90 seconds
for increased spatial resolution. Elliptical centric k-space
acquisition is advantageous for the legs. If available, time-
resolved acquisitions are preferred for the legs.
f. Parallel acquisition recommended (multichannel sur-
face coil needed)
5. AnalysisJournal of Cardiovascular Magnetic Resonance 2008, 10:35 http://www.jcmr-online.com/content/10/1/35
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a. 3D reconstructions may be helpful for an initial over-
view and visualizing the vasculature tree, but generally
should not be used for primary decision making.
b. Primary diagnoses are made by scrolling through
source images (typically coronal and/or sagittal), and
using selected thin slab MIP and MPR reconstructions in
optimized orthogonal and oblique views for each station.
The presence, number, and degree of stenoses are evalu-
ated qualitatively.
Alternative: dual injection protocol
1. Single dose of gadolinium: time-resolved MRA of the
calf and foot vessels
2. Single dose of gadolinium: abdominal and thigh ves-
sels
2.2.2. Thoracic aortic MRA
1. Localizer, 3 orientations
2. Half-fourier single shot fast spin echo or SSFP (one
breathhold, entire thorax)
Transaxial orientation.
3. Transaxial T1-weighted fast spin echo through aorta
(for intramural hematoma, dissection)
4. SSFP cine imaging in parasagittal plane parallel to aorta
Option – use 3-point piloting
5. Evaluate aortic valve as per valvular protocol
6. Contrast timing
a. Option 1 -Transaxial test bolus at level of distal abdom-
inal aorta. 2 ml injection of gadolinium, followed by 20
ml saline. Determine time to peak enhancement follow-
ing injection.
b. Option 2 – Bolus triggering technique to time start of
scan
c. Option 3 – Rapid multiphase 3D acquisitions without
timing
7. 3D gadolinium enhanced MRA (0.1–0.2 mmol/kg)
(optional – ECG-gated acquisition)a. Use spatial resolu-
tion of at least 1–1.5 mm b. Parallel acquisition if availa-
blec. At least 2 acquisitions after contrast injection
8. Optional – transaxial T2-weighted gradient echo or T1-
weighted gradient-echo post-contrast for aortitis
9. Analysis – MPR-Reconstruction, MIP and thin slab MIP
2.2.3. Anomalous coronary artery evaluation
1. LV structure and function module to look for wall
motion abnormalities
a. Add repeat horizontal long axis with high temporal res-
olution sequence (≤ 20 ms per phase) to accurately deter-
mine quiescent period of RCA
2. Navigator-gated, 3D, free-breathing, MRA sequence:
a. Transaxial slices spanning from level of proximal main
pulmonary artery down to the middle of the right atrium
(entire cardiac coverage if desired). Slice thickness 1–1.5
mm; acquired spatial resolution in-plane of 1.0 mm or
less.
b. Slices – typically 50–80, as needed to encompass vessels
of interest.
c. Adjust trigger delay and acquisition window according
to observed quiescent coronary period.
d. Parallel acquisition preferred
e. Navigator placed over the right hemi-diaphragm.
f. Optional – contrast to increase vessel conspicuity
3. Optional -
a. breathhold techniques if poor image quality or naviga-
tors unavailable or of poor quality
b. T2-prepared sequence may be useful
2.3.4. Pulmonary vein evaluation – pre- and post-ablation
1. LV structure and function module
2. Breathhold non-gated contrast-enhanced MRA per-
formed in the coronal projection encompassing the pul-
monary veins and left atrium (greater anterior coverage if
breathholding permits) (optional – optimize oblique pro-
jections, ECG-gated acquisition)
a. Gadolinium (0.1–0.2 mmol/kg) injected at 2–3 ml/s
b. Slice thickness 1–2 mm; acquired spatial resolution in-
plane 1–1.5 mm.
c. Slices – typically 60–80, as needed to encompass region
of interest.
d. Parallel acquisition used as availableJournal of Cardiovascular Magnetic Resonance 2008, 10:35 http://www.jcmr-online.com/content/10/1/35
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e. 2–3 volumetric acquisitions – each breathhold typically
no longer than 15–18s.
3. Optional – through plane phase contrast flow analysis
through each pulmonary vein.
4. Analysis
Gadolinium MRA evaluated qualitatively by scrolling
through slices in various orientations. The number and
position of pulmonary veins is accounted for noting com-
mon trunks, accessory veins, and evidence for stenosis or
thrombosis. A 3D workstation is used for MPR analysis to
calculate major and minor axes, and cross sectional area
of each pulmonary vein ostium. Compare pre- and post-
ablation images side by side. 3D rendering may facilitate
planning of surgical or electrophysiologic interventions.
2.3. Other
2.3.1. Nonischemic LV cardiomyopathies including myocarditis
1. LV structure and function module
2. Consider T2-weighted imaging in the acute setting
when necrosis/edema may be present (e.g. myocarditis)
a. Body coil should be used or alternatively functional sur-
face coil intensity correction algorithms
b. Breath-hold, segmented fast spin-echo imaging (double
inversion recovery)
c. Perform imaging prior to contrast administration
d. Selected slices based on cine imaging findings (e.g. 2
and 4-chamber long axis and 3 representative short axis
slices)
e. Adjust readout to mid-diastole
f. Slice thickness at least 10 mm
g. Slice thickness of dark blood prep if used should be
greater than the base-apex motion of the mitral annulus
3. Late Gadolinium Enhancement module
a. Analysis – Examine the "pattern" of enhancement as
certain nonischemic cardiomyopathies have predilection
for scarring in typical ways
4. Optional – adenosine stress-rest perfusion imaging or
high dose dobutamine stress functional imaging (see
stress protocols) to comment on the presence or absence
of ischemia since a mixed cardiomyopathy may be present
5. For hypertrophic cardiomyopathies -LV outflow tract
flow imaging for presence of turbulence, systolic anterior
motion, and phase velocity measures of gradient if
present.
2.3.2. Arrhythmogenic right ventricular cardiomyopathy
1. LV structure and function module – consider 5–6 mm
slice thickness
a. Careful RV as well as LV volumetric analysis.
2. Transaxial or oblique transaxial SSFP cine images cover-
ing the RV including RVOT. An RV vertical long axis view
aligned with tricuspid inflow is recommended.
3. Optional sequences
a. Selected transaxial or oblique transaxial black blood
images (double inversion recovery T1-weighted fast spin
echo).
b. Repeat same geometry with fat suppression
c. Late gadolinium enhancement module in same orienta-
tions as above. Consider T1 nulling for RV.
d. Consider use of anterior surface coil only to improve
resolution without "wrap around" artifacts.
e. Consider prone position in overweight patients in order
to minimize distance between the surface coil and RV.
Major criteria for diagnosing ARVC include severe dilation
and reduction of right ventricular ejection fraction with
no or mild left ventricular involvement; localized right
ventricular aneurysms (akinetic or dyskinetic areas with
diastolic bulgings); severe segmental dilation of right ven-
tricle. Minor criteria include mild global right ventricular
dilation or ejection fraction reduction with normal left
ventricle; mild segmental dilation of right ventricle;
regional right ventricular hypokinesia. All of these are
demonstrable by CMR as performed above. CMR also
allows assessment of fatty infiltration and myocardial
fibrosis. However, the latter two findings are not part of
current guidelines.
Note – there is variability of the structure and shape of the
RV amongst normals, so there is a tendency for inexperi-
enced observers to overdiagnose RV wall motion abnor-
malities. For example, relative end-systolic bulging of a
thin but contractile region of the RV free wall adjacent to
the moderator band can be a normal finding and basal
short axis cines may give the impression of inferior wall
dyskinesis due to normal through-plane motion. CarefulJournal of Cardiovascular Magnetic Resonance 2008, 10:35 http://www.jcmr-online.com/content/10/1/35
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study of RV cines in volunteers and a range of patients is
recommended before attempting identification of ARVC.
2.3.3. Congenital Heart Disease
For all diagnoses:
1. LV and RV structure and function module
a. In many cases, a contiguous stack of transaxial SSFP
cine images from the inferior wall of the LV through the
top of the aortic arch is recommended.
b. Gradient echo cine or hybrid gradient echo/echo planar
imaging may be added for improved detection of turbu-
lent flow in particular planes
2. Scout imaging in the plane of the ascending aorta and
main pulmonary artery.
3. Through plane velocity encoded cine imaging through
the main pulmonary artery and aorta to measure Qp and
Qs.
4. Time resolved or multiple rapid dynamic 3D gadolin-
ium enhanced magnetic resonance angiography in a coro-
nal orientation
For individual diagnoses, protocols must be individual-
ized. Additional sequences to consider:
1. For shunt lesions
a. Measurement of Qp:Qs as above
b. In plane and/or through plane velocity encoded gradi-
ent echo sequence to visualize rather than measure shunt
flow
2. For lesions involving the great vessels
a. SSFP cine imaging in parasagittal plane parallel to aorta
b. Specific alignment of cines with jet flow through aortic
coaractation, flowed by through-plane jet velocity map-
ping to measure peak velocity and recognize possible
diagnostic prolongation of forward flow
c. Assessment of valves as per valvular protocol
d. SSFP cine and/or gradient echo cine images along the
individual pulmonary arteries
e. Comparison of RPA with LPA flow volume in the case
of unilateral branch PA stenosis.
2.3.4. Valvular disease
Patients with artificial valves can safely undergo CMR at
1.5 and 3 Tesla. The force exerted by the beating heart is
many-fold higher than the force exerted by the magnetic
field.
1. LV structure and function module.
a. Use horizontal long axis to look for valve anatomy and
turbulence of the mitral and tricuspid valve.
b. Use LVOT view for mitral and aortic valve.
c. Use vertical long axis for mitral valve.
d. Coronal view for aortic valve
e. Additional views (RV long axis, RV-outflow tract as
needed).
2. Specific
a. Valve morphology assessment with SSFP cine in the
plane of the valve in question. Care must be taken to opti-
mize the level and angle of imaging
b. Note – if planimetry of a stenotic valve is to be
attempted, a contiguous or slightly overlapping stack of
high resolution cines transecting the line of the jet and
moving from orifice level to immediately downstream is
recommended. Planimetry is most likely to be valid where
the cross section of the orifice, or rather of the jet, is clearly
delineated. This may not always be the case due to frag-
mented or oblique jet flow.
c. Gradient echo or hybrid gradient echo/echo planar
imaging may visualize regurgitant jets with a higher sensi-
tivity (for qualitative purposes only).
d. In mitral or tricuspid regurgitation, a contiguous stack
of 5 mm cines is recommended aligned with the direction
of inflow and transecting the principal line of coaptation,
moving from the more superior commissure to the infe-
rior. The orientation can be that of the LVOT plane for the
mitral and transaxial for the tricuspid. Such a stack ena-
bles assessment of tethering, prolapse, or regurgitation
through the scallops of both mitral leafletes.
3. Measure flow velocity and volume perpendicular to the
vessel distal to valve leaflet tips.
a. Adapt velocity encoding to actual velocity (using lowest
velocity without aliasing).
b. Use lowest TE possible for high velocity jet flows.Publish with BioMed Central    and   every 
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c. The CMR software should routinely correct for phase
errors due to concomitant gradients. As long as this is the
case, background phase errors due to eddy currents may
be correctable by normalizing velocities to reference in
static tissue.
4. Analysis:
a. Determine left and right ventricular stroke volume
using volumetric analyses of SSFP cine sequences to meas-
ure single valve regurgitation.
b. Mitral regurgitation can be measured by subtracting
aortic flow from the LV stroke volume.
c. Multiple valve lesions can be assessed from comparison
of the aortic and pulmonary diastolic regurgitant flow and
the LV and RV stroke volumes.
d. Measure aortic valve area by direct planimetry
e. Alternatively, measure aortic valve area by (Velocity
time integral LVOT/Velocity time integral aorta) × Area
LVOT
f. Calculate peak mitral valve gradient from peak mitral
valve flow
2.3.5. Pericardial disease
1. LV structure and function module
2. T1 or T2-weighted fast spin echo images
a. 2–3 representative long axis images and 3–4 represent-
ative short axis images to measure pericardial thickness
(normal ≤ 3 mm)
b. If pericardial cyst is suspected, refer to masses protocol
3. Optional – If regions of thickened pericardium noted –
T1-weighted gradient echo myocardial tagged cine
sequences to demonstrate presence or absence of epicar-
dial/pericardial slippage (2–3 long axis images and 1–2
short axis images)
4. Optional, but encouraged if available – real-time imag-
ing in the short axis during dynamic breathing maneuvers
for evaluation of ventricular interdependence
5. Late Gadolinium Enhancement module
2.3.6. Cardiac and paracardiac masses, including thrombi
1. LV structure and function module
2. T1 weighted fast spin echo – slices through the mass
and surrounding structures (number of slices depends on
size of the mass)
3. T2 weighted fast spin echo with fat suppression
(optional – without fat suppression) – through the mass
and surrounding structures as above. See nonischemic car-
diomyopathies for sequence details.
4. First pass perfusion module with slices through mass
5. Repeat T1 weighted turbo spin echo with fat suppres-
sion
6. (optional) Repeat selected steady state free precession
cine images post-contrast
7. Late gadolinium enhancement module – note that TI to
null the mass may be different than for myocardium.
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